Truist Securities Reiterates Buy Rating on Tenet Healthcare (THC)
Tweet Send to a Friend
Truist Securities analyst David MacDonald reiterated a Buy rating and $240.00 price target on Tenet Healthcare (NYSE: THC).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
